Absci Corporation (ABSI) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Vancouver, WA, United States. El CEO actual es Sean McClain.
ABSI tiene fecha de IPO 2021-07-22, 156 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $485.08M.
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
